• Research Topics

  Retrotope Announces Initiation of Phase 2 Study of RT001 in Patients with ALS

  Posted by Richard on March 17, 2021 at 10:50 am

  Retrotope Announces Initiation of Phase 2 Study of RT001 in Patients with Amyotrophic Lateral Sclerosis (ALS). The first patients have been dosed in a multicenter Phase 2 clinical trial evaluating RT001.

  https://www.globenewswire.com/news-release/2021/03/17/2194389/0/en/Retrotope-Announces-Initiation-of-Phase-2-Study-of-RT001-in-Patients-with-Amyotrophic-Lateral-Sclerosis-ALS.html

   

  Though good news, the slow pace of research is evident by this two and half year old alsnewstoday article on RT001.

  https://alsnewstoday.com/news-posts/2018/09/18/experimental-rt001-available-for-als-under-expanded-access-program/

   

  Richard

   

  Richard replied 4 years, 1 month ago 0 Member · 0 Replies

  • ALS
  • research
• 0 Replies

Log In to Reply